Health Condition 1: I789- Disease of capillaries, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex above 18 years & below 60 years with cherry angioma. Patients willing to give a written informed consent.
Exclusion criteria
Exclusion criteria: Before starting the study Pregnant and lactating women. Women planning for pregnancy Patients with co-morbidities – DM /TB /CAD Patients with IED Patients on immunosuppressive drugs,anti coagulants , isotretinoin Bleeding and coagulation disorders, HIV , Hep B , Hep C Patients with active local infection and photoaggravated skin diseases Patients with unstable vitiligo , psoriasis and keloids During Study If patient develops severe side effects like ulceration / intolerant to pain during the treatment If patient wants alternate treatment during the study. If patient wants to discontinue the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resolution of lesions clinicallyTimepoint: One week ,one month,three months,six months for radio frequency ablation Each treatment sessions (4,8,12,16 weeks ) and 6 months for intense pulsed light | — |
Secondary
| Measure | Time frame |
|---|---|
| Scarring,hyperpigmentation , recurrence of lesionsTimepoint: 24 weeks | — |
Countries
India
Contacts
Chengalpattu medical college hospital